Skip to Main Content

In biopharma, patents are everything. In tech? Not so much.

Which is why it was unusual to see a company that’s trying to turn software into medicine announce this week that it’s bagged several patents.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!